Shingrix vaccine makes shingles less severe, disruptive to quality of life
(Reuters Health) – The vaccine Shingrix prevents shingles, and if people do contract the virus, it reduces the severity of…
GSK’s new R&D head bets on genetics with $300 million 23andMe deal
LONDON (Reuters) – GlaxoSmithKline’s new research boss aims to turbo-charge the British group’s drug discovery engine with a $300 million…
Mersana’s cancer drug trial put on hold by FDA; shares halted
(Reuters) – Mersana Therapeutics said on Thursday an early stage trial testing its lead cancer drug has been put on…
Allergan, Molecular Partners eye drug meets main goal in two studies
(Reuters) – Allergan Plc and Molecular Partners AG said on Thursday their treatment for neovascular age-related macular degeneration, a leading…
Pfizer-Lilly pain drug meets late-stage trial goals
(Reuters) – An experimental osteoarthritis drug developed by Pfizer Inc and Eli Lilly and Co achieved its main goal of…
Abbott Labs raises 2018 earnings forecast, shares hit record high
(Reuters) – Abbott Laboratories raised its full-year earnings forecast and topped estimates for quarterly profit on Wednesday, powered by demand…
CRISPR gene editing can cause risky collateral DNA damage: study
LONDON (Reuters) – Scientists studying the effects of the potentially game-changing gene editing tool CRISPR/Cas9 have found it can cause…
J&J vows to overturn $4.7 billion talc verdict but experts see hurdles
NEW YORK (Reuters) – Johnson & Johnson has vowed to appeal a $4.7 billion verdict awarded to 22 women who…
CTI Biopharma’s cancer drug fails late-stage trial, shares tumble
(Reuters) – CTI Biopharma Corp said on Monday its treatment for a type of blood cancer did not meet the…
AbbVie, AndroGel partner owe $448 million in antitrust case: U.S. judge
(Reuters) – A U.S. judge on Friday found that pharmaceutical company AbbVie Inc used sham litigation to illegally prevent generic…
Missouri appeals court tosses $55 million J&J talc-powder verdict
(Reuters) – A Missouri appeals court on Friday threw out a $55 million verdict against Johnson & Johnson in a…
Amazon to buy PillPack in potentially disruptive drug retail push
(Reuters) – Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the…
U.S. charges hundreds in major healthcare fraud, opioid crackdown
(Reuters) – The U.S. Justice Department on Thursday announced charges against 601 people including doctors for taking part in healthcare…
Ex-Akebia employee jailed for night as insider trading trial starts
BOSTON (Reuters) – A former Akebia Therapeutics Inc (AKBA.O) employee accused of engaging in an insider trading scheme must spend…
U.S. medical device firm electroCore IPO price set at $15 per share
(Reuters) – U.S. medical device maker electroCore Llc’s initial public offering is expected to price at $15 per share, Chief…
After law change, Greek medicinal users hope to enter cannabis business
XYLOKASTRO, Greece (Reuters) – Konstantinos Syros turned to cannabis 26 years ago after a motorcycle accident left him with deformed…
Theranos founder Holmes, former president indicted for fraud
(Reuters) – Theranos Inc founder Elizabeth Holmes and the embattled blood-testing company’s former president were indicted on charges that they…
Theranos founder Holmes, former president indicted for fraud
(Reuters) – Theranos Inc founder Elizabeth Holmes and the embattled blood-testing company’s former president were indicted on charges that they…
GSK’s two-drug HIV treatment meets main goal in late stage studies
(Reuters) – GlaxoSmithKline’s two-drug treatment for HIV, the virus that causes AIDS, met its main goal in late stage studies,…
Medical device maker Stryker makes takeover approach to Boston Scientific: WSJ
(Reuters) – Medical device maker Stryker Corp has made a takeover approach to rival Boston Scientific Corp, the Wall Street…
In Missouri, J&J faces biggest trial yet alleging talc caused cancer
NEW YORK (Reuters) – A lawsuit by 22 ovarian cancer patients against Johnson & Johnson went to trial on Wednesday…
Drug combination better for restoring womb after miscarriage
(Reuters Health) – Two drugs are better than one when it comes to restoring the womb after an incomplete miscarriage,…
Medical workers in Congo city finish vaccinating contacts of Ebola patients
KINSHASA (Reuters) – Medical workers in Democratic Republic of Congo have given all the immediate contacts of Ebola patients in…
Many women with early-stage breast cancer can skip chemotherapy: study
CHICAGO (Reuters) – Some 70 percent of women with early-stage breast cancer and an intermediate risk of cancer recurrence can…
Experts outline ethics issues with use of genealogy DNA to solve crimes
(Reuters Health) – With recent revelations that U.S. law enforcement can – and already has – dipped into consumer genealogy…
Novartis readies anti-sexism message for migraine drug
ZURICH (Reuters) – With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to…
Leading oncology group wary of Trump drug price proposals
CHICAGO (Reuters) – America’s leading group of cancer doctors is wary of new Trump administration proposals for lowering drug costs,…
TherapeuticsMD’s therapy for menopause-related condition gets approval
(Reuters) – Women’s healthcare company TherapeuticsMD Inc won its first-ever U.S. approval on Wednesday with the drug regulator clearing its…
WHO’s Congo Ebola plan assumes 100-300 cases over three months
GENEVA (Reuters) – The World Health Organization assumes 100-300 cases of Ebola in Democratic Republic of Congo between May and…
India steps up hunt for origin of mysterious brain-damaging virus
MUMBAI/KOCHI (Reuters) – India began a fresh round of tests to trace the origin of a rare brain-damaging virus that…
U.S. jury fails to reach verdict in latest J&J talc trial
NEW YORK (Reuters) – A South Carolina jury on Friday could not agree on a verdict in a case of…
U.S. jury fails to reach verdict in latest J&J talc trial
NEW YORK (Reuters) – A South Carolina jury on Friday could not agree on a verdict in a case of…
FDA approves BioMarin rare metabolic disorder drug, shares rise
(Reuters) – U.S. regulators on Thursday approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare metabolic disorder, sending…
Ebola patients slip out of Congo hospital as medics try to control outbreak
MBANDAKA, Democratic Republic of Congo (Reuters) – Three patients infected with the Ebola virus slipped out of an isolation ward…
Two more die of Ebola in Congo, seven new cases confirmed
MBANDAKA, Democratic Republic of Congo (Reuters) – Two more people have died from Ebola and seven new cases were confirmed…
FDA issues warning letters to companies selling kratom products
(Reuters) – The U.S. Food and Drug Administration said on Tuesday it issued warning letters to three companies that illegally…
Congo begins giving experimental Ebola vaccine to medics
MBANDAKA, Democratic Republic of Congo (Reuters) – Congo began administering an experimental Ebola vaccine to medical staff in the northwestern…
Merck KGaA’s lung cancer drugs show promise in early-stage trials
FRANKFURT (Reuters) – Germany’s Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain…
Evolus investors frown as FDA declines to approve Botox rival
(Reuters) – U.S. health regulators on Wednesday declined to approve Evolus Inc’s (EOLS.O) rival product to Allergan Plc’s (AGN.N) Botox,…
Evolus investors frown as FDA declines to approve Botox rival
(Reuters) – U.S. health regulators on Wednesday declined to approve Evolus Inc’s (EOLS.O) rival product to Allergan Plc’s (AGN.N) Botox,…
Novartis top lawyer exits in wake of Trump attorney deal
ZURICH (Reuters) – Novartis (NOVN.S) General Counsel Felix Ehrat will leave the Swiss drugmaker over his role in a $1.2…
Novartis ditches lawyer as head rolls over Trump lawyer deal
ZURICH (Reuters) – Novartis (NOVN.S) General Counsel Felix Ehrat will leave the Swiss drugmaker over his role in a $1.2…
J&J defends itself in trial over baby powder asbestos claims
(Reuters) – A trial for a lawsuit alleging that Johnson & Johnson Baby Powder was responsible for the death of…
WHO hopes to use Ebola vaccine to stem outbreak in remote area of Congo
GENEVA (Reuters) – The World Health Organization said on Friday it hopes to deploy an experimental Ebola vaccine to tackle…
Health charity Wellcome pledges funds, calls for rapid response to Ebola in Congo
(Reuters) – Britain’s Wellcome Trust global health charity called for a rapid response to an outbreak of Ebola in the…
Jazz Pharmaceuticals to settle U.S. probe for $57 million
BOSTON (Reuters) – Jazz Pharmaceuticals Plc said on Tuesday it had agreed to pay $57 million to resolve a U.S.…
FDA says Mylan’s EpiPen is in shortage
(Reuters) – U.S. regulators said on Wednesday that Mylan NV’s (MYL.O) EpiPen products are in shortage, due to manufacturing delays…
U.S. drug agency suspends Louisiana distributor over opioid sales
WASHINGTON (Reuters) – The U.S. Drug Enforcement Administration said on Friday it had suspended a Louisiana pharmaceutical distributor from selling…
FDA chief questions protections on drug rebates, stocks fall
(Reuters) – U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health…
Scientists devise new, more accurate peanut allergy test
LONDON (Reuters) – British scientists have developed a far more accurate blood test to diagnose peanut allergy, offering a better…
Regeneron/Sanofi cut heart drug price to $4,500-$6,600 for Express Scripts
(Reuters) – Regeneron Pharmaceuticals Inc and Sanofi SA will slash the price of their expensive cholesterol drug for Express Scripts…
FDA clears Pluristem radiation treatment for emergency use
HAIFA, Israel (Reuters) – Pluristem Therapeutics Inc, a developer of placenta-based stem cell products, said the U.S. Food and Drug…
Allergan migraine drug succeeds in second late-stage trial
NEW YORK (Reuters) – Allergan Plc on Friday announced positive results from a second Phase III trial for the 50…
Zimbabwe says will issue cannabis licences to growers
HARARE (Reuters) – Zimbabweans can now apply for licences to grow cannabis for medical and research purposes, the government has…
Ninety-eight now sick from romaine lettuce-linked E. coli: CDC
(Reuters) – Fourteen more people fell ill from an E. coli outbreak linked to romaine lettuce, U.S. health officials said…
Fourteen more fall sick from E. coli linked to romaine lettuce: CDC
(Reuters) – Fourteen more sick people from eight U.S. states were added to an investigation of an E. coli outbreak…
Johnson & Johnson wins appeal to overturn $151 million hip implant verdict
(Reuters) – Johnson & Johnson on Wednesday secured a favorable U.S. appellate court ruling, overturning a verdict that had awarded…
FDA cracks down on sales of Juul tobacco products to minors
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it launched a crackdown on the sale of e-cigarettes…
Jilted Akorn sues Fresenius over deal termination
FRANKFURT (Reuters) – U.S. generic drugmaker Akorn is taking former suitor Fresenius to court after the German healthcare group canceled…
FDA declines to approve Pfizer’s biosimilar to Roche’s cancer drug
(Reuters) – Pfizer Inc said on Monday the U.S. Food and Drug Administration (FDA) declined to approve the company’s biosimilar…